Predicted to enable proton-transporting ATPase activity, rotational mechanism. Predicted to be involved in cellular response to increased oxygen levels and intracellular iron ion homeostasis. Predicted to be located in several cellular components, including acrosomal vesicle; focal adhesion; and perinuclear region of cytoplasm. Predicted to be part of proton-transporting V-type ATPase, V0 domain. Human ortholog(s) of this gene implicated in autosomal recessive cutis laxa type IIA and wrinkly skin syndrome. Orthologous to human ATP6V0A2 (ATPase H+ transporting V0 subunit a2); PARTICIPATES IN oxidative phosphorylation pathway; phagocytosis pathway; rheumatoid arthritis pathway; INTERACTS WITH 6-propyl-2-thiouracil; ammonium chloride; amphetamine.
[Clofibrate co-treated with Acetaminophen] affects the expression of ATP6V0A2 mRNA and PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of ATP6V0A2 mRNA]
[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ATP6V0A2 mRNA
[Permethrin co-treated with DEET] results in decreased methylation of ATP6V0A2 gene and [Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of ATP6V0A2 mRNA
[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ATP6V0A2 mRNA
[Clofibrate co-treated with Acetaminophen] affects the expression of ATP6V0A2 mRNA and PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of ATP6V0A2 mRNA]
[Permethrin co-treated with DEET] results in decreased methylation of ATP6V0A2 gene and [Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of ATP6V0A2 mRNA
[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ATP6V0A2 mRNA